NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Domus Diagnostics

Domus Diagnostics

Private
Park City, UtahHealthcare & Life Scienceshttps://www.domusdx.com/

Last Round

Grant

May 24, 2023

Total Funding Raised

$3.9M

Company Overview

Domus Diagnostics is a diagnostic equipment company that develops affordable, user-friendly, and rapid at-home and point-of-care molecular diagnostic tests for infectious diseases.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology

Business Model

B2B

Customer Profile

Hardware Sales, Government Contracts

AI Layer

Non-AI

Keywords

nucleic acid amplification testingNAATmolecular diagnosticspoint of care testingPOCTRT-LAMPat-home diagnosticrapid testinginfectious disease testinginstrument-free diagnosticsdisposable test kitPCR-accurateglobal health diagnosticslow-cost diagnostics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Domus Diagnostics Comparables

Compare Domus Diagnostics with similar companies based on industry and business-model similarity.

Domus Diagnostics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Seek Labs
78%
Llusern Scientific
77%
OraSure Technologies Inc
77%

Domus Diagnostics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantMay 24, 2023
SeedApr 20, 2022

Domus Diagnostics Investors

Notable investors and investment history

Domus Diagnostics investors
InvestorRounds
National Institute of Biomedical Imaging and BioengineeringGrant
NIH RADxGrant
Bantam GroupSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 24, 2023

    $2M grant from National Institute of Biomedical Imaging and Bioengineering and NIH RADx.

Domus Diagnostics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Domus Diagnostics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Domus Diagnostics's valuation, stock price, and market status.

Firmographic Details

HeadquartersPark City, Utah
Employee Range2
Year Founded2021
Last FundingMay 24, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.